Search - tctmd.com

Displaying 581 - 600 of 778

Sort: Relevancy | Date

News Industry News

STENTYS Receives FDA Approval to Initiate First U.S. Clinical Trial With Self-Apposing® Stent

October 22, 2012

News Conference News TCT 2012

Second-Generation DES Safer, More Effective Than BMS in STEMI at 1 Year

October 22, 2012

News Industry News

Minneapolis Heart Institute Foundation Announces Schedule of Events at TCT Conference

October 18, 2012

News Industry News

Revascularization with OrbusNeich’s Genous™ Stent May Enable the Safe and Early Discontinuation of Dual Antiplatelet Therapy for Patients with Increased Bleeding Risk

October 12, 2012

News Daily News

Almost 1 in 10 STEMIs Caused by Stent Thrombosis

October 12, 2012

News Daily News

PCI Rates for Acute MI Lower in States with Public Reporting

Yael L. Maxwell

October 10, 2012

News Daily News

Los Índices de PCI para los IAM son Más Bajos en aquellos Estados que Facilitan Información

Yael L. Maxwell

October 10, 2012

News Daily News

Two Decades After MI, Women Show Better Survival Than Men

Yael L. Maxwell

October 03, 2012

News Industry News

STENTYS Launches New Stent-Delivery System to Facilitate Implantation in More Complex Vessel Anatomies

September 26, 2012

News Daily News

Un Registro Coreano Confirma la Superioridad de los Stents liberadores de Everolimus sobre los de Zotarolimus

September 19, 2012

News Daily News

Korean Registry Confirms Edge of Everolimus- Over Zotarolimus-Eluting Stents

September 19, 2012

News Daily News

La Estrategia Invasiva Precoz en Pacientes STEMI Mejora la Supervivencia

September 18, 2012

News Daily News

Early Invasive Strategy in NSTEMI Patients Improves Survival

September 18, 2012

News Daily News

Double Clopidogrel Loading Dose Offers No Benefit in Primary PCI Patients with CKD

L.A. McKeown

September 18, 2012

News Conference News ESC 2012

STEMI Patient Population Evolves Over 15 Years

Yael L. Maxwell

August 27, 2012

News Conference News ESC 2012

No Benefit of Intra-aortic Balloon Pump in MI Patients with Shock

August 27, 2012

News Conference News ESC 2012

Low-Dose Rivaroxaban Curbs Thrombotic Events in STEMI Patients

Caitlin E. Cox

August 27, 2012

News Conference News ESC 2012

ESC Congress 2012 Offers Slate of Guidelines, New MI Definition

Caitlin E. Cox

August 26, 2012

News Conference News ESC 2012

Comparable Long-Term Safety, Efficacy with Prasugrel, Clopidogrel in ACS

August 26, 2012

News Daily News

It’s MAGIC: Cell Therapy Reduces Long-term MACE in MI Patients

Jason Kahn

August 24, 2012

Advertisement

STENTYS Receives FDA Approval to Initiate First U.S. Clinical Trial With Self-Apposing® Stent

Second-Generation DES Safer, More Effective Than BMS in STEMI at 1 Year

Minneapolis Heart Institute Foundation Announces Schedule of Events at TCT Conference

Revascularization with OrbusNeich’s Genous™ Stent May Enable the Safe and Early Discontinuation of Dual Antiplatelet Therapy for Patients with Increased Bleeding Risk

Almost 1 in 10 STEMIs Caused by Stent Thrombosis

PCI Rates for Acute MI Lower in States with Public Reporting

Los Índices de PCI para los IAM son Más Bajos en aquellos Estados que Facilitan Información

Two Decades After MI, Women Show Better Survival Than Men

STENTYS Launches New Stent-Delivery System to Facilitate Implantation in More Complex Vessel Anatomies

Un Registro Coreano Confirma la Superioridad de los Stents liberadores de Everolimus sobre los de Zotarolimus

Korean Registry Confirms Edge of Everolimus- Over Zotarolimus-Eluting Stents

La Estrategia Invasiva Precoz en Pacientes STEMI Mejora la Supervivencia

Early Invasive Strategy in NSTEMI Patients Improves Survival

Double Clopidogrel Loading Dose Offers No Benefit in Primary PCI Patients with CKD

STEMI Patient Population Evolves Over 15 Years

No Benefit of Intra-aortic Balloon Pump in MI Patients with Shock

Low-Dose Rivaroxaban Curbs Thrombotic Events in STEMI Patients

ESC Congress 2012 Offers Slate of Guidelines, New MI Definition

Comparable Long-Term Safety, Efficacy with Prasugrel, Clopidogrel in ACS

It’s MAGIC: Cell Therapy Reduces Long-term MACE in MI Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content